Multiple Sclerosis, Relapsing-Remitting
Conditions
Keywords
MRI, evoked potentials, cognitive function, PROMs
Brief summary
This prospective study combining non conventional MRI techniques, neuropsychological screening tools, and a neurophysiological work-up using a sensitive and validated battery, will evaluate the predictive value of these measures and will explore the changes of the cognitive scores from baseline.
Detailed description
Neurologists are in need for reliable and robust predictive factors enabling to predict disease evolution and treatment response. Moreover, recent studies suggested that the evolution patterns of cognitive status in MS could be mixed, contradicting the concept that cognitive impairment in MS will inevitably increase over time. The main aim of this prospective study is to investigate the predictors of disease evolution, as measured by the EDSS score, using a multiparametric assessment combining neuropsychological tests (BCcogSEP battery), MRI-derived metrics (volumetric brain parameters, tractography, diffusion tensor imaging and fiber tracking), patient-reported outcome measures, and neurophysiological tools (multimodal evoked potentials), and to explore the evolutionary patterns of cognitive status (changes from baseline). The investigators planned to include 50 patients with active RRMS and initiating a new disease-modifying treatment. Yearly assessment starting from study inclusion will be performed.
Interventions
OTHERMultiparametric assessment
neuropsychological assessment, PRO measures, non-conventional MRI metrics
Sponsors
Saint-Luc University Hospital
University Hospital of Mont-Godinne
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
* active MS, according to the Lublin criteria * disease duration \< 10 years before initiating or changing a disease-modifying therapies, * relapse- and steroid-free for at least 1 month before MRI acquisition * between 18-50 years old * having given informed consent * with no significant comorbidity other than MS or substance abuse that could interfere with cognitive performances
Exclusion criteria
* progressive forms of MS
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Predictors of disease evolution | 3 years | EDSS score worsening from baseline |
| evaluation of evolutionary patterns of cognitive status (impaired vs non impaired)/changes from baseline | 3 years | changes from baseline in cognitive scores |
| baseline predictors of future cognitive impairment | 3 years | abnormal cognitive performances based on cognitive scores (using BCcogSEP battery) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| alteration in strategic white matter tracts at the early stages of RRMS, in patients with and without cognitive impairment | 3 years | fractional anisotropy |
| predictive role of mEPS in predicting future disability | 3 years | the Global Evoked Potential (GEP) score at study entry (baseline); EDSS score changes from baseline |
Countries
Belgium
Contacts
Primary ContactFrédéric London, MD
Outcome results
None listed